Abstract

Summary

This study validates acepromazine (5 mg/kg) and chlorpromazine (10 mg/kg) as pharmaceutical-grade alternatives to chlorprothixene for measuring pupillary light reflexes in anesthetized mice, which is important for ensuring reproducible and ethically sound in vivo photoresponse research. These findings have practical implications for laboratories studying circadian photoentrainment and melanopsin-driven pupillary responses, as they provide a safer, regulated sedation protocol without compromising measurement quality.
Abstract

Key Findings

  • Acepromazine (5 mg/kg) and chlorpromazine (10 mg/kg) were statistically indistinguishable from chlorprothixene (1 mg/kg) across all pupillary light reflex measures.
  • Saline-treated (unsedated) mice exhibited pupillary drift far more frequently than any sedative group, compromising measurement reliability.
  • Saline-treated mice took significantly longer to reach maximal pupil constriction compared to all sedative groups.
  • Saline-treated mice had lower heart rates compared to chlorpromazine- and chlorprothixene-sedated groups.
  • Full recovery (purposeful movement, tactile response, full alertness) was not regularly achieved in any sedative group, suggesting lower doses should be investigated for survival procedures.
Categories

Categories

Eye Health & Vision: Paper evaluates pupillary light reflex imaging methodology in mice, directly relevant to measuring visual and pupillary photoresponses.
The Science of Light: Study involves light-evoked responses including pupillary constriction measured under controlled photostimulus conditions (470 nm, 16.0 log photons cm⁻² s⁻¹), relevant to photoreceptor response measurement methodology.
Authors

Author(s)

SS Eckley, JS Villano, NS Kuo
Publication Date

Publication Year

2020
Citations

Number of Citations

7
View more publications